Cormorant Asset Management, LP Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$1.3T
Holdings
80
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (80 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —TURNING POINT THERAPEUTICS I | 2,484,220 | $186.9B | 14.13% | |
| 2 | DSGNDESIGN THERAPEUTICS INC | 5,500,000 | $77.0B | 5.82% | |
| 3 | ERASERASCA INC | 10,505,554 | $58.5B | 4.42% | |
| 4 | —PROMETHEUS BIOSCIENCES INC | 2,029,158 | $57.3B | 4.33% | |
| 5 | APLSAPELLIS PHARMACEUTICALS INC | 950,000 | $43.0B | 3.25% | |
| 6 | RVMDREVOLUTION MEDICINES INC | 1,995,066 | $38.9B | 2.94% | |
| 7 | BMEABIOMEA FUSION INC | 3,170,872 | $38.0B | 2.87% | |
| 8 | CCXIEURCHEMOCENTRYX INC | 1,425,000 | $35.3B | 2.67% | |
| 9 | ALTALTIMMUNE INC | 3,000,000 | $35.1B | 2.65% | |
| 10 | XBISPDR SER TR | 450,000 | $33.4B | 2.53% | Call |
| 11 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 6,065,001 | $30.9B | 2.34% | |
| 12 | EWTXEDGEWISE THERAPEUTICS INC | 3,850,000 | $30.6B | 2.32% | |
| 13 | RNAAVIDITY BIOSCIENCES INC | 2,012,115 | $29.2B | 2.21% | |
| 14 | GLUEMONTE ROSA THERAPEUTICS INC | 2,993,717 | $28.9B | 2.19% | |
| 15 | ACLXARCELLX INC | 1,525,000 | $27.6B | 2.08% | |
| 16 | TARSTARSUS PHARMACEUTICALS INC | 1,875,000 | $27.4B | 2.07% | |
| 17 | AVTEAEROVATE THERAPEUTICS INC | 1,730,691 | $27.1B | 2.05% | |
| 18 | —BIOHAVEN PHARMACTL HLDG CO L | 184,894 | $26.9B | 2.04% | |
| 19 | TORCEURADICET BIO INC | 1,800,000 | $26.3B | 1.99% | |
| 20 | PHVSPHARVARIS N V | 1,145,953 | $25.3B | 1.91% | |
| 21 | —FORMA THERAPEUTICS HLDGS INC | 3,172,204 | $21.9B | 1.65% | |
| 22 | HZNPHORIZON THERAPEUTICS PUB L | 267,500 | $21.3B | 1.61% | |
| 23 | TNGXTANGO THERAPEUTICS INC | 4,507,843 | $20.4B | 1.54% | |
| 24 | MRTXEURMIRATI THERAPEUTICS INC | 300,000 | $20.1B | 1.52% | |
| 25 | AXNX*AXONICS INC | 322,240 | $18.3B | 1.38% | |
| 26 | KRTXKARUNA THERAPEUTICS INC | 125,000 | $15.8B | 1.20% | |
| 27 | CYTKCYTOKINETICS INC | 400,000 | $15.7B | 1.19% | |
| 28 | ITCIEURINTRA-CELLULAR THERAPIES INC | 275,000 | $15.7B | 1.19% | |
| 29 | —VECTIVBIO HLDG AG | 2,840,389 | $15.3B | 1.16% | |
| 30 | —GREENLIGHT BIOSCIENCS HLDS P | 6,960,540 | $15.2B | 1.15% | |
| 31 | STOKSTOKE THERAPEUTICS INC | 1,087,807 | $14.4B | 1.09% | |
| 32 | CNTACENTESSA PHARMACEUTICALS PLC | 2,927,273 | $14.3B | 1.08% | |
| 33 | BBIOBRIDGEBIO PHARMA INC | 1,469,179 | $13.3B | 1.01% | |
| 34 | —RAIN THERAPEUTICS INC | 2,326,660 | $12.9B | 0.98% | |
| 35 | IMRXIMMUNEERING CORP | 2,286,181 | $12.4B | 0.94% | |
| 36 | RCKTROCKET PHARMACEUTICALS INC | 868,550 | $12.0B | 0.90% | |
| 37 | SWTXSPRINGWORKS THERAPEUTICS INC | 475,000 | $11.7B | 0.88% | |
| 38 | AVIRATEA PHARMACEUTICALS INC | 1,547,181 | $11.0B | 0.83% | |
| 39 | VERVVERVE THERAPEUTICS INC | 700,710 | $10.7B | 0.81% | |
| 40 | VRDNVIRIDIAN THERAPEUTICS INC | 877,500 | $10.2B | 0.77% | |
| 41 | KZRKEZAR LIFE SCIENCES INC | 1,200,000 | $9.9B | 0.75% | |
| 42 | VTYXVENTYX BIOSCIENCES INC | 780,643 | $9.5B | 0.72% | |
| 43 | OLMAOLEMA PHARMACEUTICALS INC | 2,082,000 | $8.5B | 0.64% | |
| 44 | AXSMAXSOME THERAPEUTICS INC | 205,000 | $7.9B | 0.59% | |
| 45 | —LONGBOARD PHARMACEUTICALS IN | 2,273,221 | $7.0B | 0.53% | |
| 46 | COGTCOGENT BIOSCIENCES INC | 750,000 | $6.8B | 0.51% | |
| 47 | —AMBRX BIOPHARMA INC | 2,486,386 | $6.6B | 0.50% | |
| 48 | GHRSGH RESEARCH PLC | 608,123 | $6.1B | 0.46% | |
| 49 | BCABBIOATLA INC | 2,038,215 | $5.8B | 0.44% | |
| 50 | ALXOALX ONCOLOGY HLDGS INC | 712,079 | $5.8B | 0.44% | |
| 51 | TCE2CELLDEX THERAPEUTICS INC NEW | 200,000 | $5.4B | 0.41% | |
| 52 | TYRATYRA BIOSCIENCES INC | 743,988 | $5.3B | 0.40% | |
| 53 | —TALARIS THERAPEUTICS INC | 1,174,723 | $5.3B | 0.40% | |
| 54 | ASNDASCENDIS PHARMA A/S | 50,000 | $4.6B | 0.35% | |
| 55 | PLRXPLIANT THERAPEUTICS INC | 482,413 | $3.9B | 0.29% | |
| 56 | AKROAKERO THERAPEUTICS INC | 403,787 | $3.8B | 0.29% | |
| 57 | —ICOSAVAX INC | 651,393 | $3.7B | 0.28% | |
| 58 | ELDNELEDON PHARMACEUTICALS INC | 1,305,095 | $3.2B | 0.24% | |
| 59 | —ELEVATION ONCOLOGY INC | 1,983,168 | $2.8B | 0.21% | |
| 60 | KROSKEROS THERAPEUTICS INC | 100,000 | $2.8B | 0.21% | |
| 61 | YMABUSDY-MABS THERAPEUTICS INC | 150,000 | $2.3B | 0.17% | |
| 62 | —AKOUOS INC | 394,500 | $1.9B | 0.14% | |
| 63 | GLTOUSDGALECTO INC | 1,020,238 | $1.8B | 0.13% | |
| 64 | GOSSGOSSAMER BIO INC | 198,382 | $1.7B | 0.13% | |
| 65 | PYXSPYXIS ONCOLOGY INC | 668,854 | $1.6B | 0.12% | |
| 66 | VIGLVIGIL NEUROSCIENCE INC | 616,786 | $1.6B | 0.12% | |
| 67 | CABACABALETTA BIO INC | 1,154,424 | $1.2B | 0.09% | |
| 68 | MGTXMEIRAGTX HLDGS PLC | 150,000 | $1.1B | 0.09% | |
| 69 | AUTLAUTOLUS THERAPEUTICS PLC | 392,167 | $1.1B | 0.08% | |
| 70 | CMMBCHEMOMAB THERAPEUTICS LTD | 288,168 | $1.1B | 0.08% | |
| 71 | —HARPOON THERAPEUTICS INC | 540,600 | $1.0B | 0.08% | |
| 72 | ANABANAPTYSBIO INC | 50,000 | $1.0B | 0.08% | |
| 73 | —RENOVACOR INC | 500,000 | $1.0B | 0.08% | |
| 74 | GLSHQGELESIS HLDGS INC | 626,108 | $970.0M | 0.07% | |
| 75 | CATBUSDASTRIA THERAPEUTICS INC | 300,000 | $900.0M | 0.07% | |
| 76 | BCELATRECA INC | 319,057 | $571.0M | 0.04% | |
| 77 | GRPHGRAPHITE BIO INC | 199,547 | $549.0M | 0.04% | |
| 78 | IMV1EURIMV INC | 234,374 | $155.0M | 0.01% | |
| 79 | ORTXUSDORCHARD THERAPEUTICS PLC | 256,649 | $150.0M | 0.01% | |
| 80 | ASNSUSDX4 PHARMACEUTICALS INC | 103,980 | $100.0M | 0.01% |